Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures

Kurt, Mevlut; Onal, Ibrahim; Akdogan, Meral; Kekilli, Murat; Arhan, Mehmet; Sayilir, Abdurrahim; Oztas, ERKİN; HAZNEDAROĞLU, İBRAHİM

doi:10.1155/2010/896819

Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures

Atıf İçin Kopyala

Kurt M., Onal I. K., Akdogan M., Kekilli M., Arhan M., Sayilir A., ...Daha Fazla

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, cilt.24, sa.6, ss.380-384, 2010 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 24 Sayı: 6
Basım Tarihi: 2010
Doi Numarası: 10.1155/2010/896819
Dergi Adı: CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.380-384
Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

OBJECTIVE: To assess the hemostatic efficacy of the Ankaferd Blood Stopper (ABS, Ankaferd Health Products Ltd, Turkey) hemostatic agent for controlling gastrointestinal bleeding associated with various benign lesions refractory to conventional antihemorrhagic measures.